Clinical trial
Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC…
NCT00466674 · Hospices Civils de Lyon, Other · Completed
Key facts
| NCT number | NCT00466674 |
|---|---|
| Title | Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning |
| Official title | Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning (IFM 2005-03) |
| Acronym | IFM 2005-03 |
| Lead sponsor | Hospices Civils de Lyon, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myeloma |
| Intervention type | Drug |
| Interventions | reduced intensity conditioning |
| Enrollment | 13 |
| Start date | Jan 1, 2007 |
| Primary completion | Sep 1, 2013 |
| Completion | Sep 1, 2013 |
| First posted | Apr 27, 2007 |
| Last update posted | Dec 19, 2025 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: